Ramazan ASOĞLU, Abdulmecit AFŞİN, Adem ATICI, Emin ASOĞLU

Relationship between platelet-to-lymphocyte ratio and fractional flow reserve in left anterior descending artery with intermediate stenosis

Aim: Platelet-to-lymphocyte ratio has been used as a determinant factor for coronary artery disease. Since platelet activationis central to the initiation of atherosclerosis, our goal was to evaluate the relationship between platelet-to-lymphocyte ratio andfractional flow reserve (FFR) values in the left anterior descending artery (LAD) with intermediate coronary stenosis.Material and Methods: The present report encompassed 173 subjects having stable angina pectoris. These subjects were categorizedinto 2 groups: 91 subjects with a FFR less than or equal to 0.80 and 82 patients with a FFR greater than 0.80. The platelet-tolymphocyte ratio of each subject was determined from the complete blood count. The two groups were evaluated for differencesusing a Student's unpaired t-test. A p-value of

PDF

___

1. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949–3003.
2. Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998 ;97:535–43.
3. Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213– 24.
4. Pijls NH, de Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996;334:1703–8.
5. Balta S, Celik T, Mikhailidis DP, et al. The relation between atherosclerosis and the neutrophil– lymphocyte ratio. Clin Appl Thromb 2016;22:405–11.
6. Snoep J, Roest M, Barendrecht A, et al. High platelet reactivity is associated with myocardial infarction in premenopausal women: a population- based case– control study. J Thromb Haemost 2010;8:906–13.
7. Ommen OSR, Gibbons GRJ, Hodge HDO, et al. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol 1997;79:812.
8. Azab B, Shah N, Akerman M, et al. Value of platelet/ lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis 2012;34:326–34.
9. Smith RA, Ghaneh P, Sutton R, et al. Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. J Gastrointest Surg 2008;12:1422–8.
10. Tobis J, Azarbal B, Slavin L. Assessment of intermediate severity coronary lesions in the catheterization laboratory. J Am Coll Cardiol 2007;49:839–48.
11. Pijls NH, Van Gelder B, Van der Voort P, et al. Fractional flow reserve: a useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 1995;92:3183–93.
12. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135–43.
13. Celik T, Balta S, Mikhailidis DP, et al. The relation between no-reflow phenomenon and complete blood count parameters. Angiology 2017;68:381–8.
14. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006;47:C7–12.
15. Balta S, Ozturk C. The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets 2015;26:680–1.
16. Yüksel M, Yıldız A, Oylumlu M, et al. The association between platelet/lymphocyte ratio and coronary artery disease severity. Anatol J Cardiol 2016;15:640.
17. Kurtul A, Murat SN, Yarlioglues M, et al. Association of platelet-to-lymphocyte ratio with severity and complexity of coronary artery disease in patients with acute coronary syndromes. Am J Cardiol 2014;114:972–8.
18. Davies RF, Goldberg AD, Forman S, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year followup: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997;95:2037–43.
19. Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 2000;101:1465–78.
20. Ryan TJ, Bauman WB, Kennedy JW, et al. Guidelines for percutaneous transluminal coronary angioplasty: A report of the American College of Cardiology/ American Heart Association Task Force on the Assesment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 1993;22:2033–54.
21. Abe M, Tomiyama H, Yoshida H, et al. Diastolic fractional flow reserve to assess the functional severity of moderate coronary artery stenoses: comparison with fractional flow reserve and coronary flow velocity reserve. Circulation 2000;102:2365–70.
22. Ragosta M, Bishop AH, Lipson LC, et al. Comparison between angiography and fractional flow reserve versus single-photon emission computed tomographic myocardial perfusion imaging for determining lesion significance in patients with multivessel coronary disease. Am J Cardiol 2007;99:896–902.
23. Wongpraparut N, Yalamanchili V, Pasnoori V, et al. Thirty-month outcome after fractional flow reserve– guided versus conventional multivessel percutaneous coronary intervention. Am J Cardiol 2005;96:877–84.
24. Pijls NH, van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 2007;49:2105–11.
25. Hamilos M, Muller O, Cuisset T, et al. Long-term clinical outcome after fractional flow reserve–guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation 2009;120:1505–12.
26. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008;358:331–41.
27. De Bruyne B, Fearon WF, Pijls NH, et al. Fractional flow reserve–guided PCI for stable coronary artery disease. N Engl J Med 2014;371:1208–17.
28. Muller O, Mangiacapra F, Ntalianis A, et al. Longterm follow-up after fractional flow reserve–guided treatment strategy in patients with an isolated proximal left anterior descending coronary artery stenosis. JACC Cardiovasc Interv 2011;4:1175–82.
29. Yılmaz S, Canpolat U, Başer K, et al. Neutrophil-tolymphocyte ratio predicts functionally significant coronary artery stenosis in patients with stable coronary artery disease. Archives of the Turk Society Cardiol 2018;46:129–35.